Chicago - The promise of biochemotherapy for stage IV malignant melanoma has not held up to scrutiny, and the value of this form of treatment seems nil, according to recent discouraging findings from major phase III clinical trials.
SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Spotlighting Advances in Atopic Dermatitis Research and Prevention Strategies
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
A Hairy Q&A With Jerry Shapiro, MD
The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis
2 Clarke Drive Cranbury, NJ 08512